FHL2 and breast carcinoma: Indeed, breast cancer patients with tumors expressing low amounts of FHL2 have a better survival compared to those with high intra-tumoral FHL2 expression [28] and activation of nuclear FHL2 signalling is linked to aggressiveness and recurrence of prostate cancer [27].